Patents by Inventor Weikuan Gu

Weikuan Gu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SINGLE NUCLEOTIDE POLYMORPHISMS (SNP) AND ASSOCIATION WITH RESISTANCE TO IMMUNE TOLERANCE INDUCTION
    Publication number: 20200149108
    Abstract: This application discloses methods, systems and kits for correlating the presence or absence of certain nucleic acid sequences within a population with the ability to create immune tolerance in that same population. Tolerance can be induced by solo or repeated administration of antigen, including soluble antigens administered either intravenously or sublingually. This application also discloses methods for detecting variants. In addition the application addresses the use or avoidance of non steroidal anti inflammatory drugs in therapy.
    Type: Application
    Filed: October 21, 2019
    Publication date: May 14, 2020
    Inventors: Arnold E. Postlethwaite, Weikuan Gu
  • Single nucleotide polymorphisms (SNP) and association with resistance to immune tolerance induction
    Patent number: 10450610
    Abstract: This application discloses methods, systems and kits for correlating the presence or absence of certain nucleic acid sequences within a population with the ability to create immune tolerance in that same population. Tolerance can be induced by solo or repeated administration of antigen, including soluble antigens administered either intravenously or sublingually. This application also discloses methods for detecting variants. In addition the application addresses the use or avoidance of non steroidal anti inflammatory drugs in therapy.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: October 22, 2019
    Assignee: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: Arnold E. Postlethwaite, Weikuan Gu
  • SINGLE NUCLEOTIDE POLYMORPHISMS (SNP) AND ASSOCIATION WITH RESISTANCE TO IMMUNE TOLERANCE INDUCTION
    Publication number: 20170016068
    Abstract: This application discloses methods, systems and kits for correlating the presence or absence of certain nucleic acid sequences within a population with the ability to create immune tolerance in that same population. Tolerance can be induced by solo or repeated administration of antigen, including soluble antigens administered either intravenously or sublingually. This application also discloses methods for detecting variants. In addition the application addresses the use or avoidance of non steroidal anti inflammatory drugs in therapy.
    Type: Application
    Filed: June 15, 2016
    Publication date: January 19, 2017
    Inventors: Arnold E. Postlethwaite, Weikuan Gu
  • SINGLE NUCLEOTIDE POLYMORPHISMS (SNP) AND ASSOCIATION WITH RESISTANCE TO IMMUNE TOLERANCE INDUCTION
    Publication number: 20140286971
    Abstract: This application discloses methods, systems and kits for correlating the presence or absence of certain nucleic acid sequences within a population with the ability to create immune tolerance in that same population. Tolerance can be induced by solo or repeated administration of antigen, including soluble antigens administered either intravenously or sublingually. This application also discloses methods for detecting variants. In addition the application addresses the use or avoidance of non steroidal anti inflammatory drugs in therapy.
    Type: Application
    Filed: April 3, 2014
    Publication date: September 25, 2014
    Applicant: THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: Arnold E. Postlethwaite, Weikuan Gu
  • SINGLE NUCLEOTIDE POLYMORPHISMS (SNP) AND ASSOCIATION WITH RESISTANCE TO IMMUNE TOLERANCE INDUCTION
    Publication number: 20120135014
    Abstract: This application discloses methods, systems and kits for correlating the presence or absence of certain nucleic acid sequences within a population with the ability to create immune tolerance in that same population. Tolerance can be induced by solo or repeated administration of antigen, including soluble antigens administered either intravenously or sublingually. This application also discloses methods for detecting variants. In addition the application addresses the use or avoidance of non steroidal anti inflammatory drugs in therapy.
    Type: Application
    Filed: April 20, 2009
    Publication date: May 31, 2012
    Applicant: The University of Tennessee Research Foundation
    Inventors: Arnold E. Postlethwaite, Weikuan Gu